Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease

BACKGROUND AND AIMS: Trimethylamine‐N‐oxide (TMAO), a gut microbiota‐liver metabolite, has been associated with cardiometabolic disease. However, whether TMAO is associated with nonalcoholic fatty liver disease (NAFLD) and NAFLD‐related health outcomes remains unclear. We aimed to investigate the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores‐Guerrero, Jose L., Post, Adrian, van Dijk, Peter R., Connelly, Margery A., Garcia, Erwin, Navis, Gerjan, Bakker, Stephan J. L., Dullaart, Robin P. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Metabolic & Toxic Liver Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518486/
https://www.ncbi.nlm.nih.gov/pubmed/33993608
http://dx.doi.org/10.1111/liv.14963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518486/
https://www.ncbi.nlm.nih.gov/pubmed/33993608
http://dx.doi.org/10.1111/liv.14963

Ejemplares similares